Entity
  • Circularis Biotechnologies

    Created in 2014
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    744
  • Activities

  • Technologies

  • Entity types

  • Location

    2945 Webster St, Oakland, CA 94609, USA

    Oakland

    United States of America

  • Employees

    Scale: 2-10

    Estimated: 3

  • Engaged corporates

    0
    0 0
  • Added in Motherbase

    5 years, 7 months ago
Description
  • Value proposition

    Using the power of circular RNA to control any gene, in any species, in any cell type.

    Control of any Gene in any Species or Cell Type

    Circularis has used the power of circular RNA to develop a novel method to study and regulate gene expression. This technology has enabled increased bio-therapeutic production, improved targeting of gene therapy, and optimized expression in poorly studied organisms. The elegant design and high throughput nature of this technology enables breakthrough solutions without prior knowledge of the regulatory elements or coding sequence.

    Gene Expression, Bioprocessing, Molecular Biology, Protein Expression, Drug Discovery, Promoter Discovery, Promoter Enhancement, Metabolic Engineering, Synthetic Biology, Therapeutic Promoters, Biologics, and Gene Therapy

  • Acquiring Altar and Circularis to Strengthen Our Capabilities - Ginkgo Bioworks

    We are excited to announce two new acquisitions today: Altar, a French biotechnology company that has developed a proprietary adaptive evolution platform, and Circularis, a biotechnology company with a proprietary circular RNA and promoter screening platform.

  • http://www.circularisbiotech.com
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Loading...
Loading...
Social network dynamics